Are you Dr. El-Osta?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6400 Fannin St
Suite 2900
Houston, TX 77030Phone+1 832-325-7702Fax+1 713-512-7132
Summary
- Dr. Hazem El-Osta, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas and Louisiana. He is an Assistant Professor at LA State Univ Sch of Med.
Education & Training
Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
University of Kansas (Wichita)Residency, Internal Medicine, 2006 - 2009
St Joseph's University Medical SchoolClass of 2004
Certifications & Licensure
TX State Medical License 2016 - 2025
LA State Medical License 2010 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Publications & Presentations
PubMed
- 24 citationsImmune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment.Hazem E El-Osta, Kamran Shahid, Glenn Mills, Prakash Peddi
Oncotargets and Therapy. 2016-08-16 - 9 citationsA Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invas...Magdalena L Circu, Samantha S Dykes, Jennifer Carroll, Kinsey Kelly, Floyd Galiano
Plos One. 2016-01-01 - 25 citationsModulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung c...Magdalena Circu, James Cardelli, Martin P Barr, Kenneth O'Byrne, Glenn Mills
Plos One. 2017-01-01
Other Languages
- French, Arabic
